Advertisement
Advertisement

INVA

INVA logo

Innoviva, Inc. Common Stock

22.89
USD
Sponsored
+0.09
+0.39%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

23.70

+0.81
+3.54%

Innoviva, Inc. Common Stock Profile

About

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.

Info & Links

CEO

Pavel Raifeld

Headquarters

1350 OLD BAYSHORE HIGHWAY, SUITE 400
BURLINGAME, CA 94010, UNITED STATES

Industry

Large Cap Pharmaceuticals

Sector

Medical

Website

www.inva.com

Auditor

Deloitte & Touche LLP

Share holders

53

Employees

159

Innoviva, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.75B

Enterprise Value

1.40B

Enterprise Value/EBITDA(ttm)

6.94

Price to Earnings Ratio(ttm)

5.99

Price to Sales(ttm)

4.36

Price to Book(mrq)

1.54

Price to Cash(ytd)

4.81

Profitability

Gross Margin(ttm)

75.84%

Operating Margin(ttm)

81.07%

Profit Margin(ttm)

59.39%

Return on Equity(ttm)

37.63%

Return on Invested Capital(ttm)

19.97%

Return on Assets(ttm)

23.60%

Income Statement

Revenue(ttm)

420.69M

Revenue Per Share(ttm)

5.70

Gross Profit(ttm)

310.19M

EBITDA(ttm)3

202.49M

Net Income Available to Common(ttm)

504.34M

Diluted EPS(ttm)

3.05

Share Statistics

Beta (5Y Monthly)

0.40

52-Week Change

23.20%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

73.81M

Dividend Yield

0.00%

Float4

72.41M

% Held by Insiders

2.25%

% Held by Institutions

99.12%

Balance Sheet

Total Cash(mrq)

611.93M

Total Cash Per Share(mrq)

8.29

Total Debt(mrq)

258.10M

Total Debt/Equity(mrq)

21.97%

Current Ratio(mrq)

14.64%

Quick Ratio(mrq)

13.85%

Book Value Per Share(mrq)

15.71

Cash Flow

Operating Cash Flow Per Share(ytd)

2.32

Free Cash Flow(ytd)

195.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement